• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/30/23 1:18:58 PM ET
    $AKTS
    $ATXI
    $AULT
    $AWIN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

     

    On Wednesday, 59 companies achieved new lows for the year.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Dollar Tree (NASDAQ:DLTR).
    • The company with the smallest market cap to set a new 52-week low was SenesTech (NASDAQ:SNES).
    • Outlook Therapeutics (NASDAQ:OTLK)'s stock fell the most, as it traded down 84.34% to reach a new 52-week low.
    • Dollar Tree (NASDAQ:DLTR)'s shares had the biggest turnaround, impressively rebounding 0.05% after reaching a new 52-week low.

    Here are all the stocks that set new 52-week lows on Wednesday:

    • Dollar Tree (NASDAQ:DLTR) shares moved up 0.05% on Wednesday to hit a new 52-week low of $122.00, drifting up 0.05%.
    • Hain Celestial Group (NASDAQ:HAIN) shares made a new 52-week low of $10.93 on Wednesday. The stock was up 0.32% for the day.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $1.23 this morning. The stock was down 6.06% on the session.
    • Ioneer (NASDAQ:IONR) shares hit a yearly low of $6.21. The stock was down 2.59% on the session.
    • Vanda Pharma (NASDAQ:VNDA) stock hit a yearly low of $5.26. The stock was down 3.83% for the day.
    • noco-noco (NASDAQ:NCNC) stock hit a new 52-week low of $1.62. The stock was down 13.05% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) stock hit a new 52-week low of $1.33. The stock was up 1.84% on the session.
    • Satellogic (NASDAQ:SATL) stock set a new 52-week low of $1.51 on Wednesday, moving up 1.97%.
    • Faraday Future (NASDAQ:FFIE) shares were down 12.68% for the day, having made a 52-week low of $7.18.
    • Radcom (NASDAQ:RDCM) stock set a new 52-week low of $8.56 on Wednesday, moving up 1.24%.
    • Hawthorn Bancshares (NASDAQ:HWBK) shares were down 0.71% for the day, having made a 52-week low of $16.50.
    • Akoustis Technologies (NASDAQ:AKTS) shares hit a yearly low of $1.53. The stock was down 0.93% on the session.
    • Electrovaya (NASDAQ:ELVA) shares set a new yearly low of $3.18 this morning. The stock was down 3.32% on the session.
    • Complete Solaria (NASDAQ:CSLR) stock drifted down 5.6% on Wednesday morning to hit a new 52-week low of $2.13.
    • Outlook Therapeutics (NASDAQ:OTLK) shares made a new 52-week low of $0.21 on Wednesday. The stock was down 84.34% for the day.
    • Marketwise (NASDAQ:MKTW) shares set a new yearly low of $1.24 this morning. The stock was up 0.78% on the session.
    • SEALSQ (NASDAQ:LAES) shares set a new 52-week low of $5.00. The stock traded down 14.67%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) shares made a new 52-week low of $0.85 on Wednesday. The stock was up 1.38% for the day.
    • Kentucky First Federal (NASDAQ:KFFB) stock dropped to a yearly low on Wednesday of $5.21. Shares traded down 4.58%.
    • TD Hldgs (NASDAQ:GLG) stock set a new 52-week low of $0.20 on Wednesday, moving down 28.45%.
    • Electra Battery Materials (NASDAQ:ELBM) shares set a new 52-week low of $0.65. The stock traded up 0.59%.
    • 22nd Century Group (NASDAQ:XXII) stock hit $1.56 on Wednesday morning, setting a new 52-week low for a change of down 4.71%.
    • USD Partners (NYSE:USDP) shares fell to $0.64 on Wednesday, setting a new 52-week low with a shift of down 1.99%.
    • Fusion Fuel Green (NASDAQ:HTOO) stock broke to a new 52-week low of $1.42 on Wednesday. Shares of the company traded down 16.09%.
    • BM Technologies (AMEX:BMTX) shares hit a yearly low of $1.62. The stock was up 0.61% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) shares fell to $0.19 on Wednesday, setting a new 52-week low with a shift of down 0.9%.
    • Lightning eMotors (NYSE:ZEV) stock hit $1.93 on Wednesday morning, setting a new 52-week low for a change of down 1.05%.
    • Alkaline Water Co (NASDAQ:WTER) shares set a new yearly low of $0.86 this morning. The stock was down 0.13% on the session.
    • Pulmatrix (NASDAQ:PULM) stock hit a new 52-week low of $2.33. The stock was up 2.76% on the session.
    • Avalon Holdings (AMEX:AWX) shares hit a yearly low of $2.16. The stock was down 3.94% on the session.
    • Innovative Eyewear (NASDAQ:LUCY) shares hit a yearly low of $0.58. The stock was down 2.3% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.38 on Wednesday, setting a new 52-week low with a shift of down 0.26%.
    • Avenue Therapeutics (NASDAQ:ATXI) stock drifted down 5.42% on Wednesday morning to hit a new 52-week low of $0.80.
    • Medigus (NASDAQ:MDGS) shares made a new 52-week low of $3.70 on Wednesday. The stock was up 1.41% for the day.
    • Ault Alliance (AMEX:AULT) stock achieved a new 52-week low on Wednesday morning, hitting $1.03 and moving up 0.13%.
    • Ontrak (NASDAQ:OTRK) shares were down 3.54% for the day, having made a 52-week low of $1.04.
    • Biolase (NASDAQ:BIOL) stock hit $4.35 on Wednesday morning, setting a new 52-week low for a change of down 1.97%.
    • Jeffs Brands (NASDAQ:JFBR) stock broke to a new 52-week low of $0.48 on Wednesday. Shares of the company traded down 1.98%.
    • Hallmark Financial Servs (NASDAQ:HALL) stock hit a new 52-week low of $1.95. The stock was up 1.37% on the session.
    • 1847 Holdings (AMEX:EFSH) stock drifted up 0.15% on Wednesday morning to hit a new 52-week low of $0.09.
    • Shineco (NASDAQ:SISI) shares were down 6.78% for the day, having made a 52-week low of $0.13.
    • SenesTech (NASDAQ:SNES) shares moved down 5.09% on Wednesday to hit a new 52-week low of $0.55, drifting down 5.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ATXI
    $AULT
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Hain Celestial Group Inc.
    $HAIN
    4/9/2026Outperform → Mkt Perform
    William Blair
    Hain Celestial Group Inc.
    $HAIN
    3/16/2026$0.50Equal Weight → Underweight
    Barclays
    Karyopharm Therapeutics Inc.
    $KPTI
    3/10/2026$28.00Buy
    Rodman & Renshaw
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Vanda Pharmaceuticals Inc.
    $VNDA
    3/5/2026$18.00Buy
    Truist
    Dollar Tree Inc.
    $DLTR
    2/27/2026$132.00Buy → Neutral
    Citigroup
    Satellogic Inc.
    $SATL
    2/20/2026$7.00Overweight
    Cantor Fitzgerald
    Satellogic Inc.
    $SATL
    2/18/2026$5.50Outperform
    Northland Capital
    More analyst ratings

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines

    WASHINGTON, April 9, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027 Congressional Budget Justification. The proposal would eliminate the simple statutory requirement that the FDA must review a new drug application (NDA) within 180 days of filing.In plain terms, this change would extend statutory review timelines rather than shorten them. It would replace the 180-day legal requirement with the longer Prescription Drug User Fee Act (PDUFA) and Generic Drug User Fee Amendments (GDUFA) per

    4/9/26 11:02:00 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fusion Fuel Highlights Potential Multi-Mineral Royalty Upside at Jaguar Uranium's Berlin Project as Initial Rare Earth Assessment Announced

    Planned acquisition of controlling interest in Royal Uranium expected to provide Fusion Fuel with 1.0% NSR royalty exposure to a potentially district-scale project in Colombia in connection with Jaguar's announced initial assessment program for rare earth elements in addition to uranium at the project Dublin, Ireland, April 09, 2026 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), a leading provider of full-service energy engineering, advisory, and utility solutions, today highlighted potential multi-mineral royalty income tied to the 1.0% net smelter return ("NSR") royalty held by Royal Uranium Inc. ("Royal Uranium") on the Berlin Project in Calda

    4/9/26 8:00:00 AM ET
    $HTOO
    $JAGU
    Industrial Machinery/Components
    Energy

    Electra Awards $7.8 Million in Construction Contracts for Refinery Infrastructure

    TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ:ELBM, TSXV:ELBM) ("Electra" or the "Company"), a North American critical minerals refining company, today announced the award of approximately C$7.8 million in construction contracts related to key infrastructure within its cobalt sulfate refinery in Ontario. The contracts establish defined construction scopes across key process areas, bringing additional portions of the refinery into active execution. Electra has awarded a contract valued at approximately C$6.8 million for structural, mechanical, and piping work associated with the refinery's crystallizer circuit. The work is being executed by Pro P

    4/9/26 7:30:00 AM ET
    $ELBM
    Industrial Machinery/Components
    Miscellaneous

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by O'Hara John Charles

    4 - SEALSQ Corp (0001951222) (Issuer)

    4/9/26 4:47:48 PM ET
    $LAES
    Semiconductors
    Technology

    SEC Form 4 filed by Enguent Jean-Pierre

    4 - SEALSQ Corp (0001951222) (Issuer)

    4/9/26 4:15:18 PM ET
    $LAES
    Semiconductors
    Technology

    SEC Form 4 filed by Feuardent Moreira Andreas

    4 - SEALSQ Corp (0001951222) (Issuer)

    4/8/26 4:15:09 PM ET
    $LAES
    Semiconductors
    Technology

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hain Celestial downgraded by William Blair

    William Blair downgraded Hain Celestial from Outperform to Mkt Perform

    4/9/26 8:32:41 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    Hain Celestial downgraded by Barclays with a new price target

    Barclays downgraded Hain Celestial from Equal Weight to Underweight and set a new price target of $0.50

    3/16/26 8:35:18 AM ET
    $HAIN
    Packaged Foods
    Consumer Staples

    Rodman & Renshaw initiated coverage on Karyopharm Therapeutics with a new price target

    Rodman & Renshaw initiated coverage of Karyopharm Therapeutics with a rating of Buy and set a new price target of $28.00

    3/10/26 8:41:07 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    SEC Filings

    View All

    SEC Form 424B5 filed by 22nd Century Group Inc.

    424B5 - 22nd Century Group, Inc. (0001347858) (Filer)

    4/10/26 4:35:13 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B5 filed by 22nd Century Group Inc.

    424B5 - 22nd Century Group, Inc. (0001347858) (Filer)

    4/10/26 4:30:36 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 8-K filed by Jaguar Health Inc.

    8-K - Jaguar Health, Inc. (0001585608) (Filer)

    4/9/26 5:04:50 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner

    MIAMI, March 31, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, is pleased to announce the launch of the new Lucyd Armor® Vantage style. The new smart safety frame is fully certified for workplace use under US, Canadian and European standards. The frame will debut on March 31, 2026 at the National Hardware Show: Concept to Commerce event in Las Vegas. The frame will launch on the Company's website as well as with its new premier reseller for the safety channel, Ocusafe.com.

    3/31/26 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Satellogic Appoints Former Director of NGA Vice Admiral Frank D. Whitworth III, USN (Ret.) as Strategic Advisor

    Former NGA Director to advise on strategic growth and the integration of high-frequency satellite data into global intelligence architectures NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ:SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today announced that Vice Admiral (VADM) Frank D. Whitworth III, USN (Ret.) has joined the company as a Strategic Advisor. VADM Whitworth brings decades of leadership across the U.S. defense and intelligence communities. Most recently, he served as the eighth Director of the National Geospatial-Intelligence Agency (NGA) from June 2022 until his

    3/25/26 8:30:00 AM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEALSQ Signs Letter of Intent to Acquire 100% of Miraex, a Swiss Quantum Interconnect Platform Company

    Geneva, Switzerland, March 24, 2026 (GLOBE NEWSWIRE) -- Strategic Acquisition via the SEALSQ Quantum Fund Strengthens its Quantum Vertical Stack SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or the "Company"), a subsidiary of WISeKey International Holding Ltd (NASDAQ:WKEY, SIX: WIHN)) and a leader in post-quantum semiconductor and cybersecurity solutions, today announced that it has signed a Letter of Intent ("LOI") to acquire 100% of the equity interest of Miraex SA ("Miraex"), a developer of photonics-based quantum interconnect solutions that bridge quantum processors and quantum networks, headquartered at the EPFL Innovation Park in Ecublens, Switzerland. The LOI provides for a 60-day exclusivi

    3/24/26 9:20:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Financials

    Live finance-specific insights

    View All

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Innovative Eyewear Inc. Reports Full Year 2025 Financial Results

    Revenue increased 63% over prior year Gross Profit Margins increased by 8 percentage points despite tariff headwindsMIAMI, March 25, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its full year 2025 financial results. Net revenue for the year ended December 31, 2025 was approximately $2.67 million, an increase of $1.03 million or 63% from the year ended December 31, 2024. This strong year-over-year revenue growth was primarily driven by

    3/25/26 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction

    – While Similar Symptom Improvement Was Observed Across the Two Arms Relative to Baseline, SENTRY Did Not Meet its Second Co-Primary Endpoint of Abs-TSS – – SENTRY Demonstrated a Rapid and Near Doubling of Patients Achieving SVR35 at Week 24, versus Ruxolitinib –– Promising Overall Survival Signal with >50% Reduction of Risk of Death versus Ruxolitinib –– Evidence of Potential Disease Modification with More Patients Achieving ≥20% Reductions in VAF as Early as Week 24 versus Ruxolitinib –– No New Safety Signals Identified –– Karyopharm will Meet with the FDA to Discuss the Totality of the Data and Potential sNDA Filing – – Conference Call Scheduled for Today at 8:00 a.m. ET –NEWTON, Mass., M

    3/24/26 7:00:00 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13D filed by Fusion Fuel Green PLC

    SC 13D - Fusion Fuel Green PLC (0001819794) (Filed by)

    12/6/24 6:06:39 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Fusion Fuel Green PLC

    SC 13G - Fusion Fuel Green PLC (0001819794) (Subject)

    12/3/24 4:00:02 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy